Trial Profile
Early effect of agomelatine on general interest in outpatients suffering major depressive disorder: a parallel group, randomised, double-blind, multicentre study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 May 2022
Price :
$35
*
At a glance
- Drugs Agomelatine (Primary) ; Serotonin uptake inhibitors
- Indications Major depressive disorder
- Focus Therapeutic Use
- 30 Mar 2013 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 26 Nov 2012 Planned End Date changed from 30 Sep 2012 to 30 Mar 2013 as reported by ISRCTN: Current Controlled Trials.
- 26 Nov 2012 Status changed from completed to recruiting as reported by ISRCTN: Current Controlled Trials.